NDC product
MiraLAX
NDC 11523-4357 · Bayer HealthCare LLC.
Key facts
| Product NDC | 11523-4357 |
|---|---|
| Proprietary name | MiraLAX |
| Nonproprietary name | Polyethylene Glycol 3350 |
| Substances | POLYETHYLENE GLYCOL 3350 |
| Dosage form | POWDER, FOR SOLUTION |
| Route | ORAL |
| Labeler | Bayer HealthCare LLC. |
| Product type | HUMAN OTC DRUG |
| Marketing category | NDA |
| Application number | NDA022015 |
| Pharmacologic classes | Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
| Marketing start | Feb 1, 2007 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: